These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38635872)

  • 21. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition.
    Tao S; Li L; Li L; Liu Y; Ren Q; Shi M; Liu J; Jiang J; Ma H; Huang Z; Xia Z; Pan J; Wei T; Wang Y; Li P; Lan T; Tang X; Zeng X; Lei S; Tang H; Ma L; Fu P
    Acta Diabetol; 2019 May; 56(5):581-592. PubMed ID: 30888537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial activity contributes to impaired renal metabolic homeostasis and renal pathology in STZ-induced diabetic mice.
    Wu M; Li S; Yu X; Chen W; Ma H; Shao C; Zhang Y; Zhang A; Huang S; Jia Z
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F593-F605. PubMed ID: 31268353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury.
    Cai K; Ma Y; Cai F; Huang X; Xiao L; Zhong C; Ren P; Luo Q; Chen J; Han F
    Endocrine; 2022 May; 76(2):294-303. PubMed ID: 35246764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empagliflozin ameliorates type 2 diabetes mellitus-related diabetic nephropathy via altering the gut microbiota.
    Deng L; Yang Y; Xu G
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Dec; 1867(12):159234. PubMed ID: 36185030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geniposide Improves Diabetic Nephropathy by Enhancing ULK1-Mediated Autophagy and Reducing Oxidative Stress through AMPK Activation.
    Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sanziguben polysaccharides improve diabetic nephropathy in mice by regulating gut microbiota to inhibit the TLR4/NF-κB/NLRP3 signalling pathway.
    Wang F; Liu C; Ren L; Li Y; Yang H; Yu Y; Xu W
    Pharm Biol; 2023 Dec; 61(1):427-436. PubMed ID: 36772833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low molecular weight fucoidan alleviates diabetic nephropathy by binding fibronectin and inhibiting ECM-receptor interaction in human renal mesangial cells.
    Wang J; Zhang Q; Li S; Chen Z; Tan J; Yao J; Duan D
    Int J Biol Macromol; 2020 May; 150():304-314. PubMed ID: 32057847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats.
    Zhao T; Zhang H; Yin X; Zhao H; Ma L; Yan M; Peng L; Wang Q; Dong X; Li P
    Biomed Pharmacother; 2020 Sep; 129():110325. PubMed ID: 32535383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapeseed protein-derived antioxidant peptide RAP alleviates renal fibrosis through MAPK/NF-κB signaling pathways in diabetic nephropathy.
    Zhang M; Yan Z; Bu L; An C; Wang D; Liu X; Zhang J; Yang W; Deng B; Xie J; Zhang B
    Drug Des Devel Ther; 2018; 12():1255-1268. PubMed ID: 29795979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Song W; Wei L; Du Y; Wang Y; Jiang S
    Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal Changes in Measured Glomerular Filtration Rate, Renal Fibrosis and Biomarkers in a Rat Model of Type 2 Diabetic Nephropathy.
    Su Z; Widomski D; Ma J; Namovic M; Nikkel A; Leys L; Olson L; Salte K; Donnelly-Roberts D; Esbenshade T; McGaraughty S
    Am J Nephrol; 2016; 44(5):339-353. PubMed ID: 27736813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-obesity effects of
    Zhang X; You Y; Wang L; Ai C; Huang L; Wang S; Wang Z; Song S; Zhu B
    Food Funct; 2022 Jun; 13(11):6259-6270. PubMed ID: 35593392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tea Polypeptide Ameliorates Diabetic Nephropathy through RAGE and NF-κB Signaling Pathway in Type 2 Diabetes Mice.
    Deng X; Sun L; Lai X; Xiang L; Li Q; Zhang W; Zhang L; Sun S
    J Agric Food Chem; 2018 Nov; 66(45):11957-11967. PubMed ID: 30354109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptolide Improves Renal Injury in Diabetic Nephropathy Rats through TGF-β1/Smads Signal Pathway.
    Pang R; Gu D
    Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1905-1911. PubMed ID: 34530721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling.
    Zhou X; Liu Z; Ying K; Wang H; Liu P; Ji X; Chi T; Zou L; Wang S; He Z
    Oxid Med Cell Longev; 2020; 2020():7950457. PubMed ID: 32566101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of ginsenoside Rg5 against kidney injury via inhibition of NLRP3 inflammasome activation and the MAPK signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Zhu Y; Zhu C; Yang H; Deng J; Fan D
    Pharmacol Res; 2020 May; 155():104746. PubMed ID: 32156650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renoprotective effects of Gushen Jiedu capsule on diabetic nephropathy in rats.
    Zhang L; Yang Z; Zhao Y; Yang X; Meng X; Liu J; Liu Y; Yan C; Yan D
    Sci Rep; 2020 Feb; 10(1):2040. PubMed ID: 32029775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NLRX1 does not play a role in diabetes nor the development of diabetic nephropathy induced by multiple low doses of streptozotocin.
    Scantlebery AML; Uil M; Butter LM; Poelman R; Claessen N; Girardin SE; Florquin S; Roelofs JJTH; Leemans JC
    PLoS One; 2019; 14(3):e0214437. PubMed ID: 30908533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway.
    Guo M; Gao J; Jiang L; Dai Y
    Drug Des Devel Ther; 2023; 17():2107-2118. PubMed ID: 37489175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
    Shahni R; Gnudi L; King A; Jones P; Malik AN
    Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.